Meghan M Verstraete, Maya Poffenberger, Matteo Zago, Veronica Luu, Brenda Ma, Nichole Escalante, Janessa Li, Diego Perez Escanda, Siran Cao, Edward Meier, Sifa Arrafi, Yun Peng, Anna Von Rossum, Genevieve Desjardins, Nina Weisser, Thomas Spreter von Kreudenstein
{"title":"1396 TriTCE CPI:一种新型的三特异性T细胞参与平台,集成了PD-1/PD-L1检查点抑制,用于治疗免疫抑制肿瘤","authors":"Meghan M Verstraete, Maya Poffenberger, Matteo Zago, Veronica Luu, Brenda Ma, Nichole Escalante, Janessa Li, Diego Perez Escanda, Siran Cao, Edward Meier, Sifa Arrafi, Yun Peng, Anna Von Rossum, Genevieve Desjardins, Nina Weisser, Thomas Spreter von Kreudenstein","doi":"10.1136/jitc-2023-sitc2023.1396","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":500964,"journal":{"name":"Regular and Young Investigator Award Abstracts","volume":"34 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"1396 TriTCE CPI: a novel trispecifc T cell engager platform with integrated PD-1/PD-L1 checkpoint inhibition engineered for the treatment of immunosuppressed tumors\",\"authors\":\"Meghan M Verstraete, Maya Poffenberger, Matteo Zago, Veronica Luu, Brenda Ma, Nichole Escalante, Janessa Li, Diego Perez Escanda, Siran Cao, Edward Meier, Sifa Arrafi, Yun Peng, Anna Von Rossum, Genevieve Desjardins, Nina Weisser, Thomas Spreter von Kreudenstein\",\"doi\":\"10.1136/jitc-2023-sitc2023.1396\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":500964,\"journal\":{\"name\":\"Regular and Young Investigator Award Abstracts\",\"volume\":\"34 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Regular and Young Investigator Award Abstracts\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/jitc-2023-sitc2023.1396\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Regular and Young Investigator Award Abstracts","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/jitc-2023-sitc2023.1396","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
1396 TriTCE CPI: a novel trispecifc T cell engager platform with integrated PD-1/PD-L1 checkpoint inhibition engineered for the treatment of immunosuppressed tumors